staurosporine has been researched along with B-Cell Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Mon, M; Barcenilla, H; de la Hera, A; Diaz, D; Hernandez-Fuentes, MP; Monserrat, J; Orfao, A; Prieto, A; Prieto, P; Reyes, E; Sánchez, MA | 1 |
| Hoffbrand, AV; Jabbar, SA; Wickremasinghe, RG | 1 |
| Andreeff, M; Kitada, S; Reed, JC; Zapata, JM | 1 |
| Auberger, P; Bertolotto, C; Cousin, JL; Herrant, M; Luciano, F; Mari, B; Ricci, JE | 1 |
4 other study(ies) available for staurosporine and B-Cell Leukemia
| Article | Year |
|---|---|
Loss of lineage antigens is a common feature of apoptotic lymphocytes.
Topics: Antigens, CD; Apoptosis; Cell Lineage; Flow Cytometry; Humans; Kinetics; Leukemia, B-Cell; Lymphocytes; Phytohemagglutinins; Staurosporine | 2004 |
Redox reagents and staurosporine inhibit stimulation of the transcription regulator NF-kappa B following tumour necrosis factor treatment of chronic B-leukaemia cells.
Topics: Acetylcysteine; Alkaloids; Base Sequence; Butylated Hydroxytoluene; DNA-Binding Proteins; Humans; In Vitro Techniques; Leukemia, B-Cell; Leukemia, Hairy Cell; Molecular Sequence Data; NF-kappa B; Oligodeoxyribonucleotides; Oxidation-Reduction; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1994 |
Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia.
Topics: Alkaloids; Apoptosis; Carrier Proteins; DNA Fragmentation; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Humans; In Situ Nick-End Labeling; Kinetics; Leukemia, B-Cell; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Piperidines; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Transcription Factors; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2000 |
T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Apoptotic Protease-Activating Factor 1; Blotting, Western; Burkitt Lymphoma; Caspases; Cell Survival; Cytochrome c Group; Deoxyribonucleases; DNA Fragmentation; DNA Primers; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, B-Cell; Leukemia, T-Cell; Membrane Glycoproteins; Poly-ADP-Ribose Binding Proteins; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staurosporine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |